These calls highlight the importance of legal aid not only in ensuring fairness but also in promoting social justice. In recent years, there have been efforts to address these challenges and improve access to legal aid. Various advocacy groups, including law societies, have called for a restoration of funding and a broader understanding of what constitutes a ”fair” trial. There have been calls for the expansion of legal aid in areas such as housing, education, and mental health, where many individuals are unable to afford necessary legal services.
Yet through publication in the leading dental journal, the research helped Bextra’s marketers shift attention away from the F.D.A.’s negative findings. The average age of patients in the study, 23, did not represent the population likely to take the drug, he added. SRC:MixSentence, IDs:1CB5D976;485FA936;3AD5669B;AF24C528;430C4AF5;DE757C7F;4F45A2FE;24F2A662;99219F16;FC8C0D50;63624C40;F78D37A9;1F46BF33;4F03F29E;C54A2492;1FADB78C;0ECB4049;04EFBA12;6B520626;E73F66B8;EA15627F;F3096291;39C9A45B;CEC0943E;C0692D6E;48263096;62457DA4
If this is where clinical research is headed, that would be a terrible negative trajectory,” he said. Topol – who drew attention last year with a finding that Celebrex and its competitor, Vioxx, appeared to raise the risk of heart attacks – said the Bextra studies did not include enough patients to justify drawing a broad conclusion. cannot release any information about the earlier pain studies that failed to sway regulators. ”And dentists, who have to deal with trying to prevent or modulate pain, will be impressed.” Judy Glova, a spokeswoman for Pharmacia, said the drug company stood behind the design and conclusions of the Scirex studies. Pharmacia was not trying to bypass the regulatory process, she said, adding that the company is in discussions with regulators to have Bextra approved for acute pain. Editors at The Journal of the American Dental Association said the Scirex article was reviewed by at least three scientists. Moore said he would have recommended that the journal reject the paper had he known that Bextra was not approved for acute pain. Scirex executives did not return repeated phone calls. In the early 1990’s, about 75 percent of the drug industry’s clinical research dollars went to universities, according to a study by CenterWatch, a company that tracks clinical trials. The Bextra episode is just one example of the changing face of drug research. Moore, an associate editor of the journal, said the study was ”carefully designed and rigorously performed.” But Dr. Omnicom says it has no control over Scirex. ”Even though the study lacked some important proof, the real problem is that in the dental literature, this will be read,” Dr. Harrison, said he expected Scirex’s research to produce positive results for drug company clients – results that would help speed new-drug applications, or N.D.A.’s, to the F.D.A. Yet when the ad agency paid $20 million for part-ownership of Scirex in 1999, a top Omnicom executive, Thomas L. Because of confidentiality rules, the F.D.A. By 2000, just 34 percent went to academic institutions, while the rest went to investigators working under the direction of either a private research firm like Scirex or a pharmaceutical company. ”We have nothing to do with the design of clinical studies,” said Pat Sloan, an Omnicom spokeswoman. ”Our goal,” he said, ”is to help ensure that all clinical studies and each patient accrued into a study can be assessed to support the N.D.A.
Run Every Matter Inside Microsoft. Built on Microsoft Dynamics 365 and the Power Platform and integrated in Outlook and Teams, the tool brings matter intelligence, workflow tasks, and AI assistance directly into the applications your lawyers already use every day. Litera Matter Management will be key in how we manage a large and complex legal matters with our clients. Does Litera Matter Management integrate with Microsoft Outlook and Teams? Automatically read documents, extract key dates, build task plans, and reduce manual effort, powered by Azure and Power Platform, inside your existing environment. Recruiting is not only about filling a position but also about assessing the company’s changing future needs and providing an employee who will help handle the company’s new (permanent) dynamics and succeed in development and performance. If you are you looking for more on solicitor look at the web site. SRC:MixSentence, IDs:60570297;FE559C13;89A7BC50;9BFED8BC;D70F9551;5D92B38F;4001EF39;F7D639C0;1CB5D976;226B4CE6;E39BB509;AA48DA5E;AD2F6436;DCA74BA0;1145CE81;42922DD0;F9093720;9C9F8712;C9571794;33F4E1AB;E504825E;DDF36E88;1FA912AD;C5FF299B;8A521820;39EF77DA;1526070E;7B5B1B10;103B5D06;65591CD5;EB1A3FEA;4AFB1C5A;5AD61E1B;F8FC3409;1BB88423;6A28B5B1;7C03439F;99DB29DA;149E0DEE;8FA8DBD9;E149A0AD;03D22A85;A38F7233;19C707B3
Power Apps, Power Automate, and Copilot Studio give technical teams the tools to continuously configure, automate, and extend the platform, without dependency on vendor-led change. Client profiles, matter data, time entries, and workflow notifications all surface inside the tools lawyers already use daily – eliminating the tool fragmentation that costs firms hours every week.
No listing found.